Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center

T2DM in Middle Age Ups Mortality Risk in COVID-19 Infection

T2DM in Middle Age Ups Mortality Risk in COVID-19 Infection FRIDAY, Feb. 19, 2021 -- Mortality risk from infection with COVID-19 among middle-aged adults with type 2 diabetes is elevated compared with adults without diabetes and is the equivalent of addi

Panic Attack or Heart Attack? Heres How to Tell the Difference

FRIDAY, Feb. 19, 2021 -- A heart attack and a panic attack share many similar symptoms, so its crucial to determine which one it is, experts say. Chest pain, racing heart, shortness of breath and sweating can occur with both, but only a heart attack ca

FDA Approves Verquvo

FDA Approves Verquvo FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction KENILWORTH, N.J.--(BUSINESS WIRE) January 20, 2021-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the

FDA Approves Cabenuva and Vocabria

FDA Approves Cabenuva and Vocabria FDA Approves Cabenuva (cabotegravir and rilpivirine) Long-Acting Injectable HIV Treatment and Vocabria (cabotegravir) Oral HIV Treatment London, 21 January 2021 – ViiV Healthcare, the global specialist HIV company ma